Hisashi Takasu

Title: Hisashi Takasu: Innovator in Parathyroid Hormone Research

Introduction

Hisashi Takasu is a prominent inventor based in Mishima, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of parathyroid hormone (PTH) modifications. With a total of 6 patents to his name, Takasu's work has advanced the understanding and application of biologically active peptide derivatives.

Latest Patents

One of Takasu's latest patents focuses on human parathyroid hormone modifications, specifically the preparation and use of synthetic and/or recombinant biologically active peptide derivatives of PTH(1-28). This invention includes peptides that are at least 90% identical to a specific amino acid sequence, which plays a crucial role in biological activity. Another significant patent involves screening assays for G protein-coupled receptor agonists and antagonists. This invention provides methods for determining whether a compound of interest acts as an agonist or antagonist of Gs or Gq protein-coupled receptors, utilizing stably transfected LLC-PK1 cells that express human PTHR.

Career Highlights

Takasu is currently associated with The General Hospital Corporation, where he continues to innovate in the field of hormone research. His work has implications for various medical applications, particularly in understanding and treating conditions related to parathyroid hormone.

Collaborations

Throughout his career, Takasu has collaborated with notable colleagues, including F Richard Bringhurst and Thomas J Gardella. These collaborations have further enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Hisashi Takasu's contributions to parathyroid hormone research exemplify the impact of innovative thinking in biochemistry. His patents and ongoing work continue to influence the scientific community and pave the way for future advancements.